Page last updated: 2024-10-31

netropsin and Brain Neoplasms

netropsin has been researched along with Brain Neoplasms in 1 studies

Netropsin: A basic polypeptide isolated from Streptomyces netropsis. It is cytotoxic and its strong, specific binding to A-T areas of DNA is useful to genetics research.

Brain Neoplasms: Neoplasms of the intracranial components of the central nervous system, including the cerebral hemispheres, basal ganglia, hypothalamus, thalamus, brain stem, and cerebellum. Brain neoplasms are subdivided into primary (originating from brain tissue) and secondary (i.e., metastatic) forms. Primary neoplasms are subdivided into benign and malignant forms. In general, brain tumors may also be classified by age of onset, histologic type, or presenting location in the brain.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bobola, MS1
Varadarajan, S1
Smith, NW1
Goff, RD1
Kolstoe, DD1
Blank, A1
Gold, B1
Silber, JR1

Other Studies

1 other study available for netropsin and Brain Neoplasms

ArticleYear
Human glioma cell sensitivity to the sequence-specific alkylating agent methyl-lexitropsin.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2007, Jan-15, Volume: 13, Issue:2 Pt 1

    Topics: Antineoplastic Agents; Brain Neoplasms; Cell Line, Tumor; DNA Adducts; DNA Mismatch Repair; Dose-Res

2007